Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Multiple sclerosis: managing a complex neurological disease.
Comparison of BLADE and conventional T2-TSE sequences for the sagittal visualization of the cervical spinal cord in multiple sclerosis patients - A case report.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Inflammation high-field magnetic resonance imaging.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
Care of patients with multiple sclerosis.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Month of birth as a risk factor for multiple sclerosis: an update.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis.
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
A Simple Sign for Recognizing Off-Axis OCT Measurement Beam Placement in the Context of Multicentre Studies.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Pages
« first
‹ previous
…
225
226
227
228
229
230
231
232
233
…
next ›
last »